EGFR gene signature predicts non-small cell lung cancer prognosis
Friday, January 15, 2010 - 01:21
in Health & Medicine
Epidermal growth factor receptor (EGFR) is a validated therapeutic target for non-small cell lung cancer. Researchers have now discovered a 93-gene signature that is associated with the presence of EGFR mutations in tumors from lung cancer patients and is a favorable prognostic marker in patients with early stage lung cancer.